Name | Number of supported studies | Average coverage | |
---|---|---|---|
smooth muscle cell | 9 studies | 22% ± 6% | |
fibroblast | 8 studies | 23% ± 5% | |
myofibroblast cell | 7 studies | 22% ± 4% | |
connective tissue cell | 6 studies | 29% ± 12% | |
pericyte | 6 studies | 26% ± 7% | |
neuron | 4 studies | 43% ± 16% | |
retina horizontal cell | 4 studies | 38% ± 19% | |
endothelial cell | 4 studies | 26% ± 10% | |
epithelial cell | 3 studies | 32% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 24% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 1754.75 | 328 / 328 | 100% | 33.49 | 178 / 178 |
thymus | 100% | 4541.30 | 653 / 653 | 100% | 57.24 | 605 / 605 |
prostate | 100% | 3277.78 | 245 / 245 | 100% | 54.54 | 501 / 502 |
kidney | 100% | 2519.72 | 89 / 89 | 100% | 49.35 | 899 / 901 |
brain | 100% | 3494.32 | 2636 / 2642 | 100% | 71.00 | 705 / 705 |
ovary | 100% | 2532.79 | 180 / 180 | 100% | 35.65 | 429 / 430 |
skin | 100% | 1919.29 | 1807 / 1809 | 100% | 52.72 | 471 / 472 |
uterus | 100% | 2918.75 | 170 / 170 | 98% | 49.75 | 452 / 459 |
lung | 100% | 1929.02 | 576 / 578 | 99% | 49.38 | 1140 / 1155 |
breast | 100% | 2623.18 | 459 / 459 | 98% | 43.65 | 1096 / 1118 |
liver | 100% | 1441.53 | 226 / 226 | 98% | 39.79 | 398 / 406 |
bladder | 100% | 2655.43 | 21 / 21 | 97% | 45.43 | 491 / 504 |
intestine | 100% | 2464.76 | 964 / 966 | 96% | 37.44 | 507 / 527 |
adrenal gland | 100% | 1971.08 | 258 / 258 | 93% | 37.05 | 215 / 230 |
stomach | 100% | 1985.85 | 359 / 359 | 93% | 38.02 | 267 / 286 |
esophagus | 100% | 2664.62 | 1445 / 1445 | 91% | 30.26 | 167 / 183 |
adipose | 100% | 2334.70 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3101.64 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 34.27 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.64 | 29 / 29 |
spleen | 100% | 1687.72 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.72 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.01 | 1 / 1 |
heart | 96% | 1219.70 | 823 / 861 | 0% | 0 | 0 / 0 |
muscle | 90% | 773.90 | 722 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 38% | 435.36 | 353 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009117 | Biological process | nucleotide metabolic process |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0000166 | Molecular function | nucleotide binding |
GO_0005515 | Molecular function | protein binding |
GO_0008253 | Molecular function | 5'-nucleotidase activity |
GO_0000287 | Molecular function | magnesium ion binding |
Gene name | NT5C3B |
Protein name | 5'-nucleotidase, cytosolic IIIB 7-methylguanosine phosphate-specific 5'-nucleotidase (7-methylguanosine nucleotidase) (EC 3.1.3.91) (Cytosolic 5'-nucleotidase 3B) (Cytosolic 5'-nucleotidase III-like protein) (cN-III-like protein) (EC 3.1.3.5) (N(7)-methylguanylate 5'-phosphatase) |
Synonyms | NT5C3L |
Description | FUNCTION: Specifically hydrolyzes 7-methylguanosine monophosphate (m(7)GMP) to 7-methylguanosine and inorganic phosphate . The specific activity for m(7)GMP may protect cells against undesired salvage of m(7)GMP and its incorporation into nucleic acids . Also has weak activity for CMP . UMP and purine nucleotides are poor substrates . . |
Accessions | ENST00000445655.5 C9J758 ENST00000415460.5 E5RH64 U3KQB1 Q969T7 ENST00000435506.7 [Q969T7-1] ENST00000521789.5 C9IZA4 ENST00000475053.5 E5RJR6 ENST00000486304.2 |